SCHEMBL3258559

SCHEMBL3258559

CCc1ccc(CCOc2ccc(C=O)cc2)nc1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.64
ALDH1A1 P00352 2/20 0.64
SMN1; SMN2 Q16637 2/20 0.64
LMNA P02545 1/20 0.64
MAPT P10636 1/20 0.64
PPARG P37231 4/20 0.56
CYP3A4 P08684 1/20 0.55
RXRA P19793 1/20 0.55
HRH3 Q9Y5N1 2/20 0.43
MCHR1 Q99705 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
KDM4E B2RXH2 1/20 0.40
CISD1 Q9NZ45 1/20 0.40
RAB9A P51151 1/20 0.40
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30599264 1.00 HPGD (0.64) HPGDALDH1A1SMN1; SMN2LMNAMAPT
Hydrochloric Acid SCHEMBL5168951 0.99 HPGD (0.62) HPGDALDH1A1SMN1; SMN2LMNAMAPT
Oxalic Acid SCHEMBL5167729 0.94 HPGD (0.57) HPGDALDH1A1SMN1; SMN2LMNAMAPT
Fumaric Acid SCHEMBL5168906 0.92 HPGD (0.54) HPGDALDH1A1SMN1; SMN2LMNAMAPT
Trifluoroacetic Acid SCHEMBL5180863 0.89 HPGD (0.52) HPGDALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL7905734 0.83 PPARG (0.54) HPGDALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL7905732 0.83 PPARG (0.54) HPGDALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL5167466 0.83 KDM4E (0.49) HPGDALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL18015059 0.82 PPARG (0.57) HPGDALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL10699030 0.82 PPARG (0.57) ALDH1A1SMN1; SMN2PPARGCYP3A4RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116496207-A Method for green synthesis of 4- [2- (5-ethyl-2-pyridyl) ethoxy ] benzaldehyde 上海北卡医药技术有限公司 2023-07-28 CN claimed
CN-108484488-B Method for synthesizing 4- [2- (5-ethyl-2-pyridyl) ethoxy ] benzaldehyde by photo/nickel concerted catalysis 陕西师范大学 2021-06-08 CN claimed
CN-106279144-B Method for preparing pioglitazone impurity C by one-pot method 浙江华海药业股份有限公司 2020-07-17 CN claimed
US-20090118514-A1 PROCESSES FOR PREPARING PIOGLITAZONE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS DR. REDDY'S LABORATORIES, INC. 2009-05-07 US claimed
WO-2008075380-A2 PROCESS FOR THE PREPARATION OF THIAZOLIDINE DERIVATIVES IND-SWIFT LABORATORIES LIMITED (IN) 2008-06-26 WO claimed
EP-1694646-B1 PROCESS FOR THE SYNTHESIS OF PIOGLITAZONE HYDROGEN CHLORIDE RICHTER GEDEON VEGYESZET (HU) 2007-04-25 EP claimed
EP-1694646-A1 PROCESS FOR THE SYNTHESIS OF PIOGLITAZONE HYDROGEN CHLORIDE RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2006-08-30 EP claimed
WO-2005058827-A1 PROCESS FOR THE SYNTHESIS OF PIOGLITAZONE HYDROGEN CHLORIDE Richter Gedeon Vegyészeti Gyár Rt. (HU) 2005-06-30 WO claimed
JP-9118678-A None JP disclosed
JP-5112483-A None JP disclosed
JP-10072438-A None JP disclosed
CN-116496207-A Method for green synthesis of 4- [2- (5-ethyl-2-pyridyl) ethoxy ] benzaldehyde 上海北卡医药技术有限公司 2023-07-28 CN disclosed
CN-116496207-A Method for green synthesis of 4- [2- (5-ethyl-2-pyridyl) ethoxy ] benzaldehyde 上海北卡医药技术有限公司 2023-07-28 CN disclosed
CN-116496207-A Method for green synthesis of 4- [2- (5-ethyl-2-pyridyl) ethoxy ] benzaldehyde 上海北卡医药技术有限公司 2023-07-28 CN disclosed
JP-H05112483-A PRODUCTION OF ETHER COMPOUND TAKEDA CHEM IND LTD 1993-05-07 JP disclosed
EP-0506273-A2 Method for producing ethers TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-09-30 EP disclosed
EP-0257781-B1 A METHOD FOR PRODUCING THIAZOLIDINEDIONE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 1991-09-18 EP disclosed
US-4898947-A Pyridine and thiazolidinedione derivatives TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-02-06 US disclosed
US-4812570-A Method for producing thiazolidinedione derivatives TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1989-03-14 US disclosed
EP-0257781-A1 A method for producing thiazolidinedione derivatives Takeda Chemical Industries, Ltd. (JP) 1988-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118514-A1 PROCESSES FOR PREPARING PIOGLITAZONE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS DPP4, SLC5A2, SLC5A1 HPGD 291/4885ALDH1A1 3140/4885SMN1; SMN2 1389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.